Light Chain Deposition Disease
IRB #H-25876/LCDD: High-Dose Melphalan and Autologous Stem Cell Transplantation (HDM/SCT) in Immunoglobulin Deposition Disease or Light-Chain Deposition Disease (LCDD)
IRB #H-22393/SWOG #S0115: A Phase II Trial Evaluating Modified HD Melphalan (100 mg/m2) and Auto SCT for patients with AL Amyloidosis, Light Chain Deposition Disease or High Risk Patients with MM
IRB #H-27288/Karmanos: A Multicenter Phase II Trial of Bortezomib (Velcade), Melphalan, and Dexamethasone (V-MD) in Patients with Symptomatic AL-Amyloidosis or Light Chain Deposition Disease
